Sequential high dose chemotherapy as initial treatment for aggressive sub-types of Non-Hodgkin Lymphoma: results of the international randomized phase III trial (MISTRAL)Daniel Betticher, David C. Linch, John Radford et al.|Annals of Oncology|2006Cited by 42